|
NBY Novabay Pharmaceuticals Inc 1389545 |
| Balance Sheet |
|
Current Assets
|
2,279,000 |
|
Assets
|
3,877,000 |
|
Current Liabilities
|
1,984,000 |
|
Liabilities
|
2,805,000 |
|
Equity
|
1,072,000 |
|
Shares Out
|
4,886,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-4,211,000 |
|
Investing Cash Flow
|
1,064,000 |
| Market Analysis |
Market Cap
|
2,616,417 |
|
Price
|
0.73 |
|
BVPS
|
0.22 |
|
PB
|
3.37 |
|
EPS
|
-65.91 |
|
PS
|
0.27 |
|
FCF
|
-3,147,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view NBY documents filed with the SEC.
NBY Filings
Clear
